Wize Pharma (OTCQB: WIZPD) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.
Highland Copper Company Inc. (OTCQB: HDRSF) is a Canadian copper development company focused on advancing sediment-hosted copper projects in the Copper Range District of the Upper Peninsula of Michigan, U.S.A. The Copper Range district is well known for hosting significant concentrations of copper and silver in numerous deposits. During its productive period, from 1845 to 1995, the area produced in excess of 15 billion pounds of copper.